View Financial HealthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsWacker Chemie 배당 및 자사주 매입배당 기준 점검 4/6Wacker Chemie 수익으로 충분히 충당되는 현재 수익률 10.56% 보유한 배당금 지급 회사입니다.핵심 정보10.6%배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률4.4%배당 성장률27.0%다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향81%최근 배당 및 자사주 매입 업데이트공시 • May 21Wacker Chemie Ag Approves DividendWacker Chemie AG announced that Annual Shareholders' Meeting on May 20, 2022 approved the highest dividend in the company's history. The dividend is EUR 8.00 per share, as proposed by the Executive Board and Supervisory Board.모든 업데이트 보기Recent updates공시 • Oct 23+ 2 more updatesWacker Chemie AG to Report Fiscal Year 2024 Results on Mar 12, 2025Wacker Chemie AG announced that they will report fiscal year 2024 results on Mar 12, 2025공시 • Oct 27+ 4 more updatesWacker Chemie AG to Report Q2, 2024 Results on Jul 26, 2024Wacker Chemie AG announced that they will report Q2, 2024 results on Jul 26, 2024New Risk • Jul 31New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 9.9% Last year net profit margin: 17% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings are forecast to decline by an average of 8.7% per year for the foreseeable future. Minor Risks Dividend is not well covered by cash flows (130% cash payout ratio). Profit margins are more than 30% lower than last year (9.9% net profit margin).Reported Earnings • Jul 30Second quarter 2023 earnings released: EPS: €2.38 (vs €7.67 in 2Q 2022)Second quarter 2023 results: EPS: €2.38 (down from €7.67 in 2Q 2022). Revenue: €1.75b (down 19% from 2Q 2022). Net income: €118.1m (down 69% from 2Q 2022). Profit margin: 6.7% (down from 18% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to stay flat during the next 3 years, in line with the revenue forecast for the Chemicals industry in South America.공시 • Jul 21Wacker Chemie AG Lowers Sales Guidance for the Year 2023Wacker Chemie AG lowered sales guidance for the year 2023. The company now has the following expectations: Group sales for 2023 are likely to come in between EUR 6.5 billion and EUR 6.8 billion (previous guidance: between EUR 7 billion and EUR 7.5 billion).공시 • May 18+ 1 more updateWacker Chemie AG Announces Management ChangesThe Annual Shareholders' Meeting of Wacker Chemie AG approved Patrick Cramer is a new member of the Supervisory Board. He succeeds Franz-Josef Kortüm, a long-standing member of the Supervisory Board who stepped down at the end of the Annual Shareholders' Meeting for reasons of age. Cramer has a doctorate in biochemistry and is a former professor and dean at Ludwig-Maximilians-Universität in Munich. He currently works as director of the Max Planck Institute for Multidisciplinary Sciences in Göttingen. Cramer will take up his new assignment as president of the Max Planck Society in Munich at the end of June. The Supervisory Board's proposal to elect Prof. Andreas H. Biagosch, Dr. Gregor Biebl, Matthias Biebl, Prof. Patrick Cramer, Ann-Sophie Wacker, Dr. Peter-Alexander Wacker, Prof. Anna Weber and Dr. Susanne Weiss to the Supervisory Board until the 2028 Annual Shareholders' Meeting was adopted.공시 • May 10Wacker Chemie AG acquired Biotechnology Assets, S.A from Kartesia Advisor LLP for €100 million.Wacker Chemie AG acquired Biotechnology Assets, S.A from Kartesia Advisor LLP for €100 million on May 5, 2023. WACKER will continue and grow existing customer relationships maintained by ADL BioPharma in its capacity as CMO for fermentation-based products for the food, pharmaceutical and consumer goods industries. Wacker Chemie AG completed the acquisition of Biotechnology Assets, S.A from Kartesia Advisor LLP on May 5, 2023.공시 • Oct 29Wacker Chemie AG Provides Sales Guidance for the Full Year 2022Wacker Chemie AG provided sales guidance for the full year 2022. For full year 2022, the company expects sales between EUR 8.0 billion and EUR 8.5 billion.공시 • Oct 28Wacker Chemie AG, Annual General Meeting, May 17, 2023Wacker Chemie AG, Annual General Meeting, May 17, 2023.공시 • Oct 14+ 3 more updatesWacker Chemie AG to Report Fiscal Year 2022 Final Results on Mar 14, 2023Wacker Chemie AG announced that they will report fiscal year 2022 final results on Mar 14, 2023Valuation Update With 7 Day Price Move • Sep 27Investor sentiment deteriorated over the past weekAfter last week's 20% share price decline to Mex$2,261, the stock trades at a forward P/E ratio of 6x. Average forward P/E is 6x in the Chemicals industry in South America. Total loss to shareholders of 34% over the past year. Simply Wall St's valuation model estimates the intrinsic value at Mex$3,362 per share.Reported Earnings • Aug 03Second quarter 2022 earnings released: EPS: €7.66 (vs €3.69 in 2Q 2021)Second quarter 2022 results: EPS: €7.66 (up from €3.69 in 2Q 2021). Revenue: €2.17b (up 45% from 2Q 2021). Net income: €371.8m (up 112% from 2Q 2021). Profit margin: 17% (up from 12% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 1.1% compared to a 2.7% decline forecast for the industry in Mexico.Valuation Update With 7 Day Price Move • Jul 29Investor sentiment improved over the past weekAfter last week's 16% share price gain to Mex$3,064, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 13x in the Chemicals industry globally. Simply Wall St's valuation model estimates the intrinsic value at Mex$2,853 per share.Valuation Update With 7 Day Price Move • Jul 14Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to Mex$2,652, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 12x in the Chemicals industry globally. Total loss to shareholders of 10% over the past year. Simply Wall St's valuation model estimates the intrinsic value at Mex$2,568 per share.공시 • May 21Wacker Chemie Ag Approves DividendWacker Chemie AG announced that Annual Shareholders' Meeting on May 20, 2022 approved the highest dividend in the company's history. The dividend is EUR 8.00 per share, as proposed by the Executive Board and Supervisory Board.Reported Earnings • May 01First quarter 2022 earnings released: EPS: €7.92 (vs €2.06 in 1Q 2021)First quarter 2022 results: EPS: €7.92 (up from €2.06 in 1Q 2021). Revenue: €2.08b (up 53% from 1Q 2021). Net income: €402.6m (up 278% from 1Q 2021). Profit margin: 19% (up from 7.8% in 1Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 6.8% while the industry in Mexico is not expected to grow.Reported Earnings • Mar 19Full year 2021 earnings: Revenues in line with analyst expectationsFull year 2021 results: Revenue: €6.21b (up 32% from FY 2020). Net income: €806.9m (up 327% from FY 2020). Profit margin: 13% (up from 4.0% in FY 2020). Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 7.9%, compared to a 3.1% growth forecast for the industry in Mexico.공시 • Aug 06Wacker Chemie AG Revises Earnings Guidance for the Year 2021Wacker Chemie AG revised earnings guidance for the year 2021. For the year, the company expects sales of around EUR 5.5 billion for full-year 2021 The company had previously projected sales growth in the low double-digit percentage range.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: WCH N 의 배당금 지급은 지난 10 년 동안 휘발성이었습니다.배당금 증가: WCH N 의 배당금 지급은 지난 10 년 동안 증가했습니다.배당 수익률 vs 시장Wacker Chemie 배당 수익률 vs 시장WCH N의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (WCH N)10.6%시장 하위 25% (MX)2.1%시장 상위 25% (MX)5.7%업계 평균 (Chemicals)3.7%분석가 예측 (WCH N) (최대 3년)4.4%주목할만한 배당금: WCH N 의 배당금( 10.56% )은 MX 시장에서 배당금 지급자의 하위 25%( 2.13% )보다 높습니다.고배당: WCH N 의 배당금( 10.56% )은 MX 시장( 5.7% )주주 대상 이익 배당수익 보장: 현재 지불 비율 ( 80.7% )에서 WCH N 의 지불은 수입으로 충당됩니다.주주 현금 배당현금 흐름 범위: 현금 지급 비율 ( 129.6% )이 높기 때문에 WCH N 의 배당금 지급은 현금 흐름으로 잘 충당되지 않습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YMX 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2023/10/22 23:59종가2023/07/25 00:00수익2023/06/30연간 수익2022/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Wacker Chemie AG는 31명의 분석가가 다루고 있습니다. 이 중 14명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Gerhard SchwarzBaader Helvea Equity ResearchKonstantin WiechertBaader Helvea Equity ResearchLaura Lopez PinedaBaader Helvea Equity Research28명의 분석가 더 보기
공시 • May 21Wacker Chemie Ag Approves DividendWacker Chemie AG announced that Annual Shareholders' Meeting on May 20, 2022 approved the highest dividend in the company's history. The dividend is EUR 8.00 per share, as proposed by the Executive Board and Supervisory Board.
공시 • Oct 23+ 2 more updatesWacker Chemie AG to Report Fiscal Year 2024 Results on Mar 12, 2025Wacker Chemie AG announced that they will report fiscal year 2024 results on Mar 12, 2025
공시 • Oct 27+ 4 more updatesWacker Chemie AG to Report Q2, 2024 Results on Jul 26, 2024Wacker Chemie AG announced that they will report Q2, 2024 results on Jul 26, 2024
New Risk • Jul 31New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 9.9% Last year net profit margin: 17% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings are forecast to decline by an average of 8.7% per year for the foreseeable future. Minor Risks Dividend is not well covered by cash flows (130% cash payout ratio). Profit margins are more than 30% lower than last year (9.9% net profit margin).
Reported Earnings • Jul 30Second quarter 2023 earnings released: EPS: €2.38 (vs €7.67 in 2Q 2022)Second quarter 2023 results: EPS: €2.38 (down from €7.67 in 2Q 2022). Revenue: €1.75b (down 19% from 2Q 2022). Net income: €118.1m (down 69% from 2Q 2022). Profit margin: 6.7% (down from 18% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to stay flat during the next 3 years, in line with the revenue forecast for the Chemicals industry in South America.
공시 • Jul 21Wacker Chemie AG Lowers Sales Guidance for the Year 2023Wacker Chemie AG lowered sales guidance for the year 2023. The company now has the following expectations: Group sales for 2023 are likely to come in between EUR 6.5 billion and EUR 6.8 billion (previous guidance: between EUR 7 billion and EUR 7.5 billion).
공시 • May 18+ 1 more updateWacker Chemie AG Announces Management ChangesThe Annual Shareholders' Meeting of Wacker Chemie AG approved Patrick Cramer is a new member of the Supervisory Board. He succeeds Franz-Josef Kortüm, a long-standing member of the Supervisory Board who stepped down at the end of the Annual Shareholders' Meeting for reasons of age. Cramer has a doctorate in biochemistry and is a former professor and dean at Ludwig-Maximilians-Universität in Munich. He currently works as director of the Max Planck Institute for Multidisciplinary Sciences in Göttingen. Cramer will take up his new assignment as president of the Max Planck Society in Munich at the end of June. The Supervisory Board's proposal to elect Prof. Andreas H. Biagosch, Dr. Gregor Biebl, Matthias Biebl, Prof. Patrick Cramer, Ann-Sophie Wacker, Dr. Peter-Alexander Wacker, Prof. Anna Weber and Dr. Susanne Weiss to the Supervisory Board until the 2028 Annual Shareholders' Meeting was adopted.
공시 • May 10Wacker Chemie AG acquired Biotechnology Assets, S.A from Kartesia Advisor LLP for €100 million.Wacker Chemie AG acquired Biotechnology Assets, S.A from Kartesia Advisor LLP for €100 million on May 5, 2023. WACKER will continue and grow existing customer relationships maintained by ADL BioPharma in its capacity as CMO for fermentation-based products for the food, pharmaceutical and consumer goods industries. Wacker Chemie AG completed the acquisition of Biotechnology Assets, S.A from Kartesia Advisor LLP on May 5, 2023.
공시 • Oct 29Wacker Chemie AG Provides Sales Guidance for the Full Year 2022Wacker Chemie AG provided sales guidance for the full year 2022. For full year 2022, the company expects sales between EUR 8.0 billion and EUR 8.5 billion.
공시 • Oct 28Wacker Chemie AG, Annual General Meeting, May 17, 2023Wacker Chemie AG, Annual General Meeting, May 17, 2023.
공시 • Oct 14+ 3 more updatesWacker Chemie AG to Report Fiscal Year 2022 Final Results on Mar 14, 2023Wacker Chemie AG announced that they will report fiscal year 2022 final results on Mar 14, 2023
Valuation Update With 7 Day Price Move • Sep 27Investor sentiment deteriorated over the past weekAfter last week's 20% share price decline to Mex$2,261, the stock trades at a forward P/E ratio of 6x. Average forward P/E is 6x in the Chemicals industry in South America. Total loss to shareholders of 34% over the past year. Simply Wall St's valuation model estimates the intrinsic value at Mex$3,362 per share.
Reported Earnings • Aug 03Second quarter 2022 earnings released: EPS: €7.66 (vs €3.69 in 2Q 2021)Second quarter 2022 results: EPS: €7.66 (up from €3.69 in 2Q 2021). Revenue: €2.17b (up 45% from 2Q 2021). Net income: €371.8m (up 112% from 2Q 2021). Profit margin: 17% (up from 12% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 1.1% compared to a 2.7% decline forecast for the industry in Mexico.
Valuation Update With 7 Day Price Move • Jul 29Investor sentiment improved over the past weekAfter last week's 16% share price gain to Mex$3,064, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 13x in the Chemicals industry globally. Simply Wall St's valuation model estimates the intrinsic value at Mex$2,853 per share.
Valuation Update With 7 Day Price Move • Jul 14Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to Mex$2,652, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 12x in the Chemicals industry globally. Total loss to shareholders of 10% over the past year. Simply Wall St's valuation model estimates the intrinsic value at Mex$2,568 per share.
공시 • May 21Wacker Chemie Ag Approves DividendWacker Chemie AG announced that Annual Shareholders' Meeting on May 20, 2022 approved the highest dividend in the company's history. The dividend is EUR 8.00 per share, as proposed by the Executive Board and Supervisory Board.
Reported Earnings • May 01First quarter 2022 earnings released: EPS: €7.92 (vs €2.06 in 1Q 2021)First quarter 2022 results: EPS: €7.92 (up from €2.06 in 1Q 2021). Revenue: €2.08b (up 53% from 1Q 2021). Net income: €402.6m (up 278% from 1Q 2021). Profit margin: 19% (up from 7.8% in 1Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 6.8% while the industry in Mexico is not expected to grow.
Reported Earnings • Mar 19Full year 2021 earnings: Revenues in line with analyst expectationsFull year 2021 results: Revenue: €6.21b (up 32% from FY 2020). Net income: €806.9m (up 327% from FY 2020). Profit margin: 13% (up from 4.0% in FY 2020). Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 7.9%, compared to a 3.1% growth forecast for the industry in Mexico.
공시 • Aug 06Wacker Chemie AG Revises Earnings Guidance for the Year 2021Wacker Chemie AG revised earnings guidance for the year 2021. For the year, the company expects sales of around EUR 5.5 billion for full-year 2021 The company had previously projected sales growth in the low double-digit percentage range.